Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
STAC3 binding to CaV1.1 II-III loop is nonessential but critically supports skeletal muscle excitation-contraction coupling
Wietske E. Tuinte, Enikő Török, Petronel Tuluc, Fabiana Fattori, Adele D’Amico, Marta Campiglio
Wietske E. Tuinte, Enikő Török, Petronel Tuluc, Fabiana Fattori, Adele D’Amico, Marta Campiglio
View: Text | PDF
Research Article Muscle biology Neuroscience

STAC3 binding to CaV1.1 II-III loop is nonessential but critically supports skeletal muscle excitation-contraction coupling

  • Text
  • PDF
Abstract

Skeletal muscle excitation-contraction (EC) coupling depends on the direct coupling between CaV1.1 on the sarcolemma and ryanodine receptor (RyR1) on the sarcoplasmic reticulum. A key regulator of this process is STAC3, a protein essential for both the functional expression of CaV1.1 and its conformational coupling with RyR1. Mutations in Stac3 cause STAC3 disorder, a congenital myopathy characterized by muscle weakness. STAC3 interacts with CaV1.1 in 2 key regions: the II-III loop and the proximal C-terminus. While the II-III loop has been previously found to be essential for skeletal muscle EC coupling, here we demonstrated that the interaction between STAC3 and the proximal C-terminus is necessary and sufficient for CaV1.1 functional expression and minimal EC coupling. In contrast, the interaction with the II-III loop is not essential for EC coupling, though it plays a facilitating role in enhancing the process. Supporting this finding, we identified a patient with STAC3 disorder carrying a mutation that deletes the domain of STAC3 involved in the II-III loop interaction. Collectively, our results established that STAC3 binding to CaV1.1 C-terminus is essential for its functional expression, whereas STAC3 interaction with the II-III loop serves to enhance the conformational coupling with RyR1.

Authors

Wietske E. Tuinte, Enikő Török, Petronel Tuluc, Fabiana Fattori, Adele D’Amico, Marta Campiglio

×

Figure 8

The STAC3-CT-β1a fragment rescues the reduced EC coupling in STAC3 disorder.

Options: View larger image (or click on image) Download as PowerPoint
The STAC3-CT-β1a fragment rescues the reduced EC coupling in STAC3 disor...
(A) Cartoon showing the STAC3 mutation and fragment reconstituted together with CaV1.1 in CaV1.1/Stac3-KO myotubes and relative representative calcium current and calcium release traces. (B) Average peak I-V relationships (left) and peak current amplitudes (right), 1-way ANOVA F (2, 26) = 4.578, P = 0.0198. The stars on the graph represent the results of Dunnett’s multiple-comparison test: STAC3-W280S *P = 0.0498, STAC3-W280S + STAC3-CT-β1a *P = 0.0176. (C) Average peak change in fluorescence normalized by baseline (ΔF/F0) as a function of test potential (left) and ΔF/F0 peak values (right). One-way ANOVA F (2, 26) = 11.88, P = 0.0002. Dunnett’s multiple-comparison test: ***P = 0.0001. STAC3 n = 10, STAC3-W280S n = 8, STAC3-W280S + STAC3-CT-β1a n = 11.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts